Nova Leap Health Corp. Engages Torrey Hills Capital
NOT FOR DISSEMINATION IN THE UNITED STATES OR FOR DISTRIBUTION TO U.S. NEWSWIRE SERVICES AND DOES NOT CONSTITUTE AN OFFER OF THE SECURITIES DESCRIBED HEREIN
HALIFAX, NOVA SCOTIA – April 15, 2019 – NOVA LEAP HEALTH CORP. (TSXV: NLH) (“Nova Leap” or the “Company”) is pleased to announce an agreement (the “Agreement”) with San Diego Torrey Hills Capital, Inc. (“Torrey Hills Capital”), a Rancho Santa Fe, California based investor relations firm, to provide market awareness and investor relations activities in compliance with regulatory guidelines. All amounts are in United States dollars unless otherwise specified.
Torrey Hills Capital is a leading investor and financial public relations firm specializing in small and microcap companies. Torrey Hills Capital will increase awareness of Nova Leap through its established relationships with investment professionals, investment advisors and money managers focused on the microcap market space. This will allow the Company to build and maintain an informed investor audience in both the U.S. and Canadian marketplaces.
In consideration of the services to be provided, the monthly fees incurred by Nova Leap will be cash consideration of $5,500 starting April 15, 2019 for a period of four months ending on August 15, 2019 and monthly thereafter, subject to a 30-day termination notice by either party. Nova Leap and Torrey Hills Capital are unrelated and unaffiliated entities. Torrey Hills Capital does not have any interest, directly or indirectly, in Nova Leap or its securities, or any right or intent to acquire such an interest. The Agreement is subject to regulatory approval.
About Nova Leap
Nova Leap is an acquisitive home health care services company operating in one of the fastest growing industries in the U.S. & Canada. The Company performs a vital role within the continuum of care with an individual and family centered focus, particularly those requiring dementia care. Nova Leap achieved 877% revenue growth in 2018 through a geographically focused expansion plan and achieved the #10 Ranking in the 2019 TSX Venture 50™ in the Clean Technology & Life Sciences sector. The Company is geographically diversified with operations in 4 different U.S. states: Vermont, New Hampshire, Massachusetts, and Rhode Island as well as Halifax, Nova Scotia.
About Torrey Hills Capital
Torrey Hills Capital was formed in 1998 and is headquartered in Rancho Santa Fe, California. The team of professionals offers experience and expertise in investor relations, corporate communications, non-deal road shows, and market support activities. Torrey Hills Capital specializes in the development and marketing of emerging growth companies which trade in the United States (NYSE, AMEX, and OTC) and in Canada (TSX, TSX-V, and CSE). Marketing activities articulate key investment attributes, strategic direction and financial expectations which combine to ensure that client market value fully reflects past achievements and future opportunities. Further information is available at www.torreyhillscapital.com.
FORWARD LOOKING INFORMATION:
Certain information in this press release may contain forward-looking statements. This information is based on current expectations that are subject to significant risks and uncertainties that are difficult to predict. Actual results might differ materially from results suggested in any forward-looking statements. The Company assumes no obligation to update the forward-looking statements, or to update the reasons why actual results could differ from those reflected in the forward looking-statements unless and until required by securities laws applicable to the Company. Additional information identifying risks and uncertainties is contained in the Company’s filings with the Canadian securities regulators, which filings are available at www.sedar.com.
For further information:
Christopher Dobbin, CPA, CA,
Director, President and CEO Nova Leap Health Corp.,
T: 902 401 9480 F: 902 482 5177
Neither TSX Venture Exchange nor its Regulation Services Provider (as that term is defined in the policies of the TSX Venture Exchange) accepts responsibility for the adequacy or accuracy of this release.